Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 3

Status

Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Melanoma 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Sarcoma, Clear Cell 1Rectal Neoplasms 1Radiation-induced Oral Mucositis 1Prostatic Neoplasms 1Prostate Cancer Recurrent 1Platinum-resistant Epithelial Ovarian Cancer 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Lung Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1Anatomic Stage I Breast Cancer AJCC v8 1Adenocarcinoma of Lung 1

Interventions

Trastuzumab 62Paclitaxel 57Cyclophosphamide 44pembrolizumab 34Fulvestrant 34Capecitabine 29Carboplatin 26Docetaxel 23Letrozole 22Doxorubicin 19palbociclib 16abemaciclib 16pertuzumab 15durvalumab 14Filgrastim 13Everolimus 13ribociclib 12Lapatinib 12Gemcitabine 12exemestane 11eribulin 11Vinorelbine 11Albumin-Bound Paclitaxel 11Bevacizumab 10trastuzumab deruxtecan 9neratinib 9fludarabine 9Taxes 9Radiotherapy 9Peripheral Blood Stem Cell Transplantation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Breast Neoplasms × Hydroxychloroquine × Clear all
NCT06328387 2024-03-25

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1/2 Unknown
120 enrolled
Breast

Breast Neoplasms

NCT00765765 2023-08-09

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Rutgers, The State University of New Jersey

Phase 1/2 Terminated
6 enrolled 7 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT03400254 2020-04-28

GLACIER

Abramson Cancer Center at Penn Medicine

Phase 1/2 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡